Pseudophrynaminol: A potent noncompetitive blocker of nicotinic receptor-channels

Biochemical Pharmacology

Volumn 53, Issue 5, 1997, Pages 671-676

  Badio, Barbara ^a   Garraffo, H Martin ^a   Padgett, William L ^a   Greig, Nigel H ^b   Daly, John W ^c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

acetylcholinesterase; nicotinic receptors; noncompetitive blockers; physostigmine; pseudophrynamines

Indexed keywords

NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PSEUDOPHRYNAMINOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDULLOBLASTOMA; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT;

ADULT; ANIMALS; CHOLINESTERASE INHIBITORS; HUMANS; INDOLES; NICOTINIC ANTAGONISTS; PC12 CELLS; PHYSOSTIGMINE; PYRROLES; RATS; SODIUM; SODIUM CHANNELS;

EID: 0030991757     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00878-7     Document Type: Article

References (26)

1. Spande TF, Edwards MW, Pannell LK, Daly JW, Erspamer V and Melchiorri P, Pseudophrynamine A: An unusual prenyl pyrrolo[2,3-b]indole ester from an Australian frog, Pseudophryne coriacea (Myobatrachidae). J Org Chem 53: 1222-1226, 1988.
2. Daly JW, Garraffo HM, Pannell LK and Spande TF, Alkaloids from Australian frogs (Myobatrachidae): Pseudophrynamines and pumiliotoxins. J Nat Prod 53: 407-421, 1990.
3. Taylor P, Anticholinesterase agents. In: The Pharmacological Basis of Therapeutics (Eds. Gilman AG, Goodman LS, Rall TW and Murad F), 110-129. Macmillan Publishing Co., New York, 1985.
4. Shaw KP, Aracava Y, Akaike A, Daly JW, Rickett DL and Albuquerque EX, The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol Pharmacol 28: 527-538, 1985.
5. Wachtel RE, Physostigmine block of ion channels activated by acetylcholine in BC3H1 cells. Mol Pharmacol 44: 1051-1055, 1993.
6. Reist EJ, Junga IG and Baker BR, Potential anticancer agents. XXXVII. Monofunctional aziridines related to tetramin. J Org Chem 25: 1673-1674, 1960.
7. Daly JW, Nishizawa Y, Edwards MW, Waters JA and Aronstam RS, Nicotinic receptor-elicited sodium-flux in rat pheochromocytoma PC12 cells: Effects of agonists, antagonists and noncompetitive blockers. Neurochem Res 16: 489-500, 1991.
8. 3H](-)-nicotine label the same recognition site in rat brain. Mol Pharmacol 31: 169-174, 1986.
9. Marks MJ, Stitzel JA, Romm E, Wehner JM and Collins AC, Nicotine binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and α-bungarotoxin. Mol Pharmacol 30: 427-436, 1986.
10. Hollingsworth EB, McNeal ET, Burton JL, Williams RJ, Daly JW and Creveling CR, Biochemical characterization of a filtered synaptoneurosome preparation from guinea pig cerebral cortex: Cyclic adenosine 3′:5′-monophosphate-generating systems, receptors, and enzymes. J Neurosci 5: 2240-2253, 1985.
11. Gusovsky F, McNeal ET and Daly JW, Stimulation of phosphoinositide breakdown in brain synaptoneurosomes by agents that activate sodium influx: Antagonism by tetrodotoxin, saxitoxin and cadmium. Mol Pharmacol 32: 479-487, 1987.
12. Ellman GL, Courtney KD, Andres V Jr and Featherstone RM, A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95, 1961.
13. Atack JR, Yu QS, Soncrant TT, Brossi A and Rapoport S, Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterase. J Pharmacol Exp Ther 249: 194-202, 1989.
14. Karlin A, The anatomy of a receptor. Neurosci Commen 1: 111-123, 1983.
15. Changeux J-P, Devillers-Thiery A and Chemouilli P, Acetylcholine receptor: An allosteric protein. Science 225: 1335-1345, 1984.
16. Spivak CE, Maleque MA, Oliveira AC, Masukawa LM, Tokuyama T, Daly JW and Albuquerque EX, Actions of the histrionicotoxins at the ion channel of the nicotinic acetyl-choline receptor and at the voltage-sensitive channels of muscle membranes. Mol Pharmacol 21: 351-361, 1982.
17. Aronstam RS, Daly JW, Spande TF, Narayanan TK and Albuquerque EX, Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochem Res 11: 1227-1240, 1986.
18. Daly JW, Nishizawa Y, Padgett WL, Tokuyama T, McCloskey PJ, Waykole L, Schultz AG and Aronstam RS, Decahydroquinoline alkaloids: Noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax. Neurochem Res 16: 1207-1212, 1991.
19. Daly JW, Nishizawa Y, Padgett WL, Tokuyama T, Smith AL, Holmes AB, Kibayashi C and Aronstam RS, 5,8-Disubstituted indolizidines: A new class of noncompetitive blockers for nicotinic receptor-channels. Neurochem Res 16: 1213-1218, 1991.
20. Badio B, Shi D, Shin Y, Hutchinson KD, Padgett WL and Daly JW, Spiropyrrolizidines: A new class of blockers of nicotinic receptors. Biochem Pharmacol 52: 933-939, 1996.
21. Mitchell MO and Le Quesne PW, Total synthesis of (±)-pseudophrynaminol. Tetrahedron Lett 31: 2681-2684, 1990.
22. Cozzi PG, Palazzi C, Potenza D, Scolastico C and Sun WY, Total synthesis of (±)-pseudophrynamine A. Tetrahedron Lett 31: 5661-5664, 1990.
23. 2 receptor. J Pharmacol Exp Ther 276: 289-297, 1996.
24. Brossi A, Schonenberger B, Clark OE and Ray R, Inhibition of acetylcholinesterase from electric eel by (-) and (+)-physostigmine and related compounds. FEBS Lett 201: 190-192, 1986.
25. Cohen JB, Weber M and Changeux J-P, Effects of local anesthetics and calcium on the interaction of cholinergic ligands with the nicotinic receptor protein from Torpedo marmorata. Mol Pharmacol 10: 904-932, 1974.
26. McKay DB and Trent-Sanchez P, Effect of noncompetitive nicotinic receptor blockers on catecholamine release from cultured adrenal chromaffin cells. Pharmacology 40: 224-230, 1990.